awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48257941-74D998C7-105F-4A3E-AFB4-1DBF7C103CDC
Q48257941-74D998C7-105F-4A3E-AFB4-1DBF7C103CDC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48257941-74D998C7-105F-4A3E-AFB4-1DBF7C103CDC
177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?
P2860
Q48257941-74D998C7-105F-4A3E-AFB4-1DBF7C103CDC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48257941-74D998C7-105F-4A3E-AFB4-1DBF7C103CDC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da159c733bd72dee59e10211c3ed864f8dd9e3be
P2860
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.